Page last updated: 2024-10-26

doxazosin and Acute Respiratory Distress Syndrome

doxazosin has been researched along with Acute Respiratory Distress Syndrome in 1 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Koenecke, A1
Powell, M1
Xiong, R1
Shen, Z1
Fischer, N1
Huq, S1
Khalafallah, AM1
Trevisan, M1
Sparen, P1
Carrero, JJ1
Nishimura, A1
Caffo, B1
Stuart, EA1
Bai, R1
Staedtke, V1
Thomas, DL1
Papadopoulos, N1
Kinzler, KW1
Vogelstein, B1
Zhou, S1
Bettegowda, C1
Konig, MF1
Mensh, BD1
Vogelstein, JT1
Athey, S1

Other Studies

1 other study available for doxazosin and Acute Respiratory Distress Syndrome

ArticleYear
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.
    eLife, 2021, 06-11, Volume: 10

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Ag

2021